SCHEMBL6135621

SCHEMBL6135621

CCOC(=O)[C@@](C)(N)c1ccc(Br)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 3/20 0.50
LMNA P02545 3/20 0.50
CYP1A2 P05177 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
ALDH1A1 P00352 3/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
KMT2A Q03164 6/20 0.47
MAPT P10636 5/20 0.47
MEN1 O00255 4/20 0.47
S1PR4 O95977 1/20 0.47
S1PR1 P21453 1/20 0.47
MAPK1 P28482 1/20 0.47
KDM4E B2RXH2 2/20 0.43
NPC1 O15118 1/20 0.43
RECQL P46063 1/20 0.43
RAB9A P51151 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HPGD P15428 1/20 0.41
PTPN1 P18031 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL204187 1.00 NPSR1 (0.50) NPSR1LMNACYP1A2SMN1; SMN2ALDH1A1
SCHEMBL6135476 1.00 NPSR1 (0.50) NPSR1LMNACYP1A2SMN1; SMN2ALDH1A1
SCHEMBL8907388 0.86 CNR2 (0.44) NPSR1LMNACYP1A2SMN1; SMN2CYP2C9
SCHEMBL13070710 0.83 TSHR (0.40) NPSR1LMNACYP1A2SMN1; SMN2ALDH1A1
SCHEMBL2490473 0.83 CYP3A4 (0.58) NPSR1CYP1A2SMN1; SMN2ALDH1A1CYP2C9
SCHEMBL18982867 0.83 ALDH1A1 (0.49) NPSR1LMNACYP1A2SMN1; SMN2ALDH1A1
SCHEMBL9211 0.83 ALDH1A1 (0.49) NPSR1LMNACYP1A2SMN1; SMN2ALDH1A1
SCHEMBL1455978 0.83 PIN1 (0.51) NPSR1SMN1; SMN2ALDH1A1CYP2C19KMT2A
SCHEMBL27731921 0.83 PIN1 (0.51) NPSR1SMN1; SMN2ALDH1A1CYP2C19KMT2A
SCHEMBL27752471 0.83 PIN1 (0.51) NPSR1SMN1; SMN2ALDH1A1CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0811616-B1 Salts of 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4-methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3-phenyl-propionic acid ethylester AVENTIS PHARMA GMBH (DE) 2005-05-04 EP disclosed
EP-0823898-B1 HYDANTOINE DERIVATIVES AS INTERMEDIATE PRODUCTS FOR ACTIVE PHARMACEUTICAL AGENTS HOECHST AG (DE) 2003-02-26 EP disclosed
EP-0823898-A1 HYDANTOINE DERIVATIVES AS INTERMEDIATE PRODUCTS FOR ACTIVE PHARMACEUTICAL AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1998-02-18 EP disclosed
EP-0811616-A1 Salts of 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4-methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3-phenyl-propionic acid ethylester HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-10 EP disclosed
WO-1996033976-A1 HYDANTOINE DERIVATIVES AS INTERMEDIATE PRODUCTS FOR ACTIVE PHARMACEUTICAL AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1996-10-31 WO disclosed